Type 2 Diabetes

Physical Activity and Type 2 Diabetes: When and How Much?

Both the timing and amount of physical activity are important in risk reduction and management of type 2 diabetes.

SUSTAIN-6: Cardiovascular Safety of Semaglutide in Type 2 Diabetes

Researchers found the cardiovascular safety of semaglutide was noninferior to placebo in high-risk patients with type 2 diabetes.

How Do We Use Technology for Diabetes Management?

Edward C. Chao, DO, highlights important considerations for developing technology for diabetes management.

Implementing Diabetes Self-Management Education in Type 2 Diabetes

Joan K. Bardsley, MBA, RN, CDE, describes a joint position statement regarding implementation of diabetes self-management education.

Role of the Gut Microbiome in Diabetes

Research shows that further understanding of the gut microbiome may improve diagnosis, prevention, and treatment of the disease earlier in life.

Preventing Diabetes and Complications: What Are the Challenges?

A change in how patients and physicians view diabetes may is necessary for preventing the disease and its complications.

LEADER: Liraglutide Decreased Rate of CV Events in High-Risk Type 2 Diabetes

Compared with placebo, liraglutide decreased the rate of cardiovascular events in high-risk patients with diabetes.

SGLT2 Inhibitors: A Class Effect?

Data on cardiovascular benefits as well as adverse effects have thrust this class of diabetes drugs into the spotlight.

Physical Activity Deficiency: A New Risk Factor for Type 2 Diabetes?

Sedentary behaviors may boost risk for type 2 diabetes by 22% and risk for metabolic syndrome by 39%.

AACE Issues Consensus Statement on Outpatient Glucose Monitoring in Diabetes

The new consensus statement reflects the advances made in glucose monitoring technology and offers guidance for clinicians.

AACE/ACE Updates Algorithm for Type 2 Diabetes Management

The American Association of Clinical Endocrinologists' updated algorithm for type 2 diabetes management addresses lifestyle modifications and obesity treatments.

Video

Latest Headlines

Higher Complications, Comorbidities in Youth With Type 2 Versus Type 1 Diabetes

Higher Complications, Comorbidities in Youth With Type 2 Versus Type 1 Diabetes

The prevalence of complications associated with type 1 and type 2 diabetes diagnosed during childhood and adolescence was compared in a multicenter, observational study.

Do Higher Temperatures Increase Diabetes Incidence?

Do Higher Temperatures Increase Diabetes Incidence?

Age-adjusted diabetes incidence increased for every 1 degree celcius temperature increase.

Factors Associated With Lack of Diabetes Disease Awareness Identified

Factors Associated With Lack of Diabetes Disease Awareness Identified

A study found approximately one-third of people with diabetes were undiagnosed or unaware of the diagnosis.

Mortality In Type 2 Diabetes Increased With Severe Hypoglycemia Episode

Mortality In Type 2 Diabetes Increased With Severe Hypoglycemia Episode

Researchers identified hypoglycemia as an "under-recognized" risk factor for death and CVD in people with type 2 diabetes.

Brief Intensive Lifestyle and Drug Therapy Beneficial in Type 2 Diabetes

Brief Intensive Lifestyle and Drug Therapy Beneficial in Type 2 Diabetes

Participants who received either an 8- or 16-week course of intensive lifestyle and drug therapy achieved hemoglobin A1c criteria for complete or partial diabetes remission.

Differential Adverse Renal Effects With Dapagliflozin, Empagliflozin in Type 2 Diabetes

Differential Adverse Renal Effects With Dapagliflozin, Empagliflozin in Type 2 Diabetes

A comprehensive systematic review analyzes whether specific sodium-glucose cotransporter 2 inhibitors were more likely to be associated with adverse renal events in patients with type 2 diabetes.

Update: ADA Standards of Medical Care in Diabetes Emphasize Metformin Therapy

Update: ADA Standards of Medical Care in Diabetes Emphasize Metformin Therapy

An update to the ADA's 2017 Standards of Medical Care in Diabetes indicates that, barring contraindication, patients with type 2 diabetes should undergo metformin therapy as first-line treatment.

A Clinician's Plea for More Pragmatic Clinical Trials in Diabetes

A Clinician's Plea for More Pragmatic Clinical Trials in Diabetes

Studies designed to address real-world challenges can potentially lead to both better-informed clinical decision making and improved outcomes.

Ethnicity-Based Variations in Type 2 Diabetes Risk

Ethnicity-Based Variations in Type 2 Diabetes Risk

Study participants of South Asian ethnicity were more more likely to develop type 2 diabetes with a BMI between 18 and 30 kg/m2.

Insulin Therapy in Pregnant Women With Preexisting Diabetes

Insulin Therapy in Pregnant Women With Preexisting Diabetes

Insulin types and regimens should be determined on an individual basis since there is insufficient data to support one treatment over another.

Sign Up for Free e-Newsletters